Amid an uptick of fresh COVID-19 cases in the country, the Drugs Controller General of India (DCGI) approved the emergency use authorisation for two anti-coronavirus vaccines in children between five and 12.
About:
Biological E’s Corbevax has been approved for administration in children between the ages of five and 12 and Bharat Biotech’s Covaxin has been approved for restricted use in emergency situations in the 6-12 age group.
Currently, Bharat Biotech’s inactivated whole virion vaccine is being administered in children aged 15-18, and Biological E’s protein sub-unit vaccine in children between 12 and 15 under a national COVID-19 immunisation programme.
The DCGI has also cleared ZyCoV-D’s two-dose regimen for children aged over 12. The second dose of the vaccine can be administered on the 28th day.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
